0000874716-22-000007 Sample Contracts

AGREEMENT
Supply Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York

THIS AGREEMENT is made effective as of the 16th day of October, 2003, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).

AutoNDA by SimpleDocs
AMENDMENT NO. 3 TO AGREEMENT
Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

AMENDMENT, effective as of December 28, 2011 (this “Amendment”) to the Agreement, dated as of October 17, 2003, between IDEXX Europe B.V. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc. (“OCD”).

Restricted Stock Unit Agreement
Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT NO. 4 TO AGREEMENT
Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

AMENDMENT, effective as of December 28, 2011 (this “Amendment”) to the Agreement, dated as of October 16, 2003, between IDEXX Operations, Inc. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc. (“OCD”).

CEO Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan
Stock Option Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
Director Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan
Director Stock Option Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
CEO Restricted Stock Unit Agreement
Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Employee Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2018 Stock Incentive Plan
Employee Stock Option Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT NO. 6 TO AGREEMENT
Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

THIS AMENDMENT NO.6 TO AGREEMENT (this “Amendment”) is made effective as of September 1, 2021, between IDEXX Europe B.V., a corporation organized under the law of the Netherlands (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD” or “Ortho”; each of IDEXX and Ortho also a “Party” and together also the “Parties”).

AMENDMENT NO. 8 TO AGREEMENT
Amendment No. 8 to Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances

THIS AMENDMENT NO.8 TO AGREEMENT (this “Amendment”) is made effective as of September 1, 2021, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 east Shelby Drive, Memphis Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD” or “Ortho”; each of IDEXX and Ortho also a “Party” and together also the “Parties”).

Director Restricted Stock Unit Agreement
Director Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Employee Restricted Stock Unit Agreement
Employee Restricted Stock Unit Agreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!